Investor · Saskatoon, Saskatchewan, Canada

Larry Holbrook

Open Larry in the network graph →

Filings

12

SEC Form D

Connections

51

co-filers

Capital

$15.4M

across filings

Active

Dec 2019

to Dec 2021

Most-connected co-filers (51)

Keith Carpenter · Saskatoon, Saskatchewan, Canada7 shared Rob Harding · Saskatoon, Saskatchewan, Canada6 shared Christine Rogers · Scottsdale, AZ4 shared N. Lerer Hippeau Ventures Management, Llc · New York, NY4 shared Eric N. Hippeau · New York, NY4 shared N. Lerer Hippeau Ventures Management, Llc · New York, NY4 shared Leonardo Salgado · San Francisco, CA4 shared Benjamin N. Lerer · New York, NY4 shared N. Lerer Hippeau Ventures Management, Llc · New York, NY4 shared Robert A. Kelly · Los Angeles, CA4 shared Kenneth N. Lerer · New York, NY4 shared Corey Kossack · Scottsdale, AZ4 shared Brian Yomak · Scottsdale, AZ4 shared Richard Hoyt · Saskatoon, Saskatchewan, Canada3 shared John Knowles · Saskatoon, Saskatchewan, Canada3 shared Michelle Gursky · Saskatoon, Saskatchewan, Canada3 shared Brent Zettl · Saskatoon, Saskatchewan, Canada3 shared Donald Ching · Saskatoon, Saskatchewan, Canada3 shared Daniel Goodman · HOUSTON, TX2 shared William Roberts · Grand Cayman, Cayman Islands2 shared Peter Siegel · Asbury Park, NJ2 shared Gus R. Rossi · New York, NY2 shared Andrew Byington · NEW YORK, NY2 shared John Noonan · CHEVY CHASE, MD2 shared

Recent filings (12)

Expanding Capital II, LPDec 2021 · 2 co-filers$150.0M Lerer Hippeau Select Fund III, LPJul 2021 · 14 co-filers$84.1M Lerer Hippeau VII, LPJul 2021 · 14 co-filers$130.0M Zyus Life Sciences Inc.Jan 2021 · 23 co-filers$19.2M Expanding Capital II, LPDec 2020 · 2 co-filers$150.0M Zyus Life Sciences Inc.Dec 2020 · 23 co-filers$312K Expanding Capital II-A, LPMar 2020 · 2 co-filers$30.0M Lerer Hippeau Select Fund III, LPDec 2019 · 14 co-filers$100.0M Expanding Capital II, LPDec 2019 · 2 co-filers$150.0M Lerer Hippeau VII, LPDec 2019 · 14 co-filers$130.0M Zyus Life Sciences Inc.Aug 2019 · 6 co-filers$18.1M CanniMed Therapeutics Inc.Jan 2017 · 23 co-filers$5.2M CanniMed Therapeutics Inc.Jan 2017 · 23 co-filers$5.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Larry in the interactive graph →